TP53 and ovarian neoplasm: To identify genes potentially involved in cisplatin response of ovarian tumors with wild-type p53, we conducted gene expression profiling of the A2780 cell line (wild-type p53) and OVCA420 (mutant p53; c.818G > A; p.R273H).